Jeremy Felce

SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo

Stephen K Burley, Spencer Emtage, Shane Atwell, 2009, Molecular Cancer Therapeutics.

Carbonic Anhydrases Fused to Anion Transporters of the SulP Family: Evidence for a Novel Type of Bicarbonate Transporter

Jeremy Felce, M. Saier Jr., 2005, Journal of Molecular Microbiology and Biotechnology.

Selective inhibition of MET protein receptor tyrosine kinase by SGX523

J. M. Sauder, S. Burley, J. Blaney, 2007 .

In vitro and in vivo antitumor activities of SGX523, a novel MET inhibitor

S. Burley, Marshall C. Peterman, K. Froning, 2007 .